nprnews_____ = ||| lubuntu at wor2 1TXN|||U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."

-




class="imagewrap has-source-dimensions"
data-crop-type="wide"
style="
--source-width: 6000;
--source-height: 3374;
"
>




U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns







The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine, shown here in a hospital in Denver.



David Zalubowski/AP


hide caption





toggle caption




David Zalubowski/AP













Coronavirus Updates




U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns



In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."